Andres Forero‐Torres
- Oncology top 0.2%
- Pathology and Forensic Medicine top 0.1%
- Immunology top 1%
- Genetics top 0.5%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Nancy L. BartlettDana A. KennedyAnas YounesEric L. SieversJohn P. LeonardCarmel M. LynchJoseph D. RosenblattRanjana H. Advani
- Topics
- Lymphoma Diagnosis and Treatment (90 papers)Chronic Lymphocytic Leukemia Research (43 papers)CAR-T cell therapy research (35 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Andres Forero‐Torres
159 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 5.1k
- Pathology and Forensic Medicine 3.5k
- Immunology 1.6k
- Genetics 1.4k
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Andres Forero‐Torres
This map shows the geographic impact of Andres Forero‐Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andres Forero‐Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andres Forero‐Torres more than expected).
Fields of papers citing papers by Andres Forero‐Torres
This network shows the impact of papers produced by Andres Forero‐Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andres Forero‐Torres. The network helps show where Andres Forero‐Torres may publish in the future.
Co-authorship network of co-authors of Andres Forero‐Torres
This figure shows the co-authorship network connecting the top 25 collaborators of Andres Forero‐Torres. A scholar is included among the top collaborators of Andres Forero‐Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andres Forero‐Torres. Andres Forero‐Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 107 | |
| 4 | 144 | |
| 5 | 30 | |
| 6 | 28 | |
| 7 | 158 | |
| 8 | 11 | |
| 9 | 3 | |
| 10 | 95 | |
| 11 | 43 | |
| 12 | 75 | |
| 13 | 12 | |
| 14 | 72 | |
| 15 | 54 | |
| 16 | 34 | |
| 17 | 55 | |
| 18 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphomabreakdown → | 1014 |
| 19 | 160 | |
| 20 | 15 |
About Andres Forero‐Torres
Andres Forero‐Torres is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 162 papers that have together received 7.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (90 papers), Chronic Lymphocytic Leukemia Research (43 papers) and CAR-T cell therapy research (35 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.5k citations), Oncology (5.1k citations) and Genetics (1.4k citations). Andres Forero‐Torres has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Nancy L. Bartlett, Dana A. Kennedy, Anas Younes, Eric L. Sievers, John P. Leonard, Carmel M. Lynch, Joseph D. Rosenblatt, Ranjana H. Advani, Robert Chen and Stephen M. Ansell. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.